Bonvini RF, Rastan A, Sixt S, et al. Endovascular treatment of common femoral artery disease: medium-term outcomes of 360 consecutive procedures. J Am Coll Cardiol 2011; 58:792-8.
DOI: 10.1016/j.jacc.2011.01.070
Bonvini RF, Rastan A, Sixt S, et al. Angioplasty and provisional stent treatment of common femoral artery lesions. J Vasc Interv Radiol 2013;24:175-83.
DOI: 10.1016/j.jvir.2012.10.020
Stricker H, Jacomella V. Stent-assisted angioplasty at the level of the common femoral artery bifurcation: midterm outcomes. J Endovasc Ther 2004;11:281-6.
DOI: 10.1583/03-1169.1
Ballotta E, Gruppo M, Mazzalai F, et al. Common femoral artery endarterectomy for occlusive disease: an 8-year single-center prospective study. Surgery 2010;147(2):268-74.
DOI: 10.1016/j.surg.2009.08.004
Kim JH, So BJ, Byun SJ, et al. The Advantage of Common Femoral Endarterectomy Alone or Combined with Endovascular Treatment. Vasc Specialist Int 2018;34(3):65-71.
DOI: 10.5758/vsi.2018.34.3.65
Pecoraro F, Pakeliani D, Bruno S, et al. Simultaneous Hybrid Treatment of Multilevel Peripheral Arterial Disease in Patients with Chronic Limb-Threatening Ischemia. J Clin Med 2021;10(13):2865.
DOI: 10.3390/jcm10132865
Wong G, Lahsaei S, Aoun J, et al. Management of common femoral artery occlusive disease: A review of endovascular treatment strategies and outcomes. Catheter Cardiovasc Interv 2019;93(3):514-21.
DOI: 10.1002/ccd.27983
Kang JL, Patel VI, Conrad MF, et al. Common femoral artery occlusive disease: contemporary results following surgical endarterectomy. J Vasc Surg 2008;48(4):872-7.
DOI: 10.1016/j.jvs.2008.05.025
Setacci C, de Donato G, Teraa M, et al. Chapter IV: Treatment of critical limb ischaemia. Eur J Vasc Endovasc Surg 2011;42(Suppl.2):S43-59.
DOI: 10.1016/S1078-5884(11)60014-2
Aboyans V, Ricco JB, Bartelink MEL, et al. ESC Scientific Document Group. 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS): Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteriesEndorsed by: the European Stroke Organization (ESO)The Task Force for the Diagnosis and Treatment of Peripheral Arterial Diseases of the European Society of Cardiology (ESC) and of the European Society for Vascular Surgery (ESVS). Eur Heart J 2018;39(9):763-816.
DOI: 10.1093/eurheartj/ehx095
Kithcart AP, Beckman JA. ACC/AHA versus ESC Guidelines for Diagnosis and Management of Peripheral Artery Disease: JACC Guideline Comparison. J Am Coll Cardiol 2018;72(22):2789-801. DOI : 10.1016/j. jacc.2018.09.041
DOI: 10.1016/j.jacc.2018.09.041
Primary Panel; Abramson BL, Al-Omran M, Anand SS, et al. Canadian Cardiovascular Society 2022 Guidelines for Peripheral Arterial Disease. Can J Cardiol 2022;38(5):560- 87.
DOI: 10.1016/j.cjca.2022.02.029
Boufi M, Ejargue M, Gaye M, et al. Systematic review and meta-analysis of endovascular versus open repair for common femoral artery atherosclerosis treatment. J Vasc Surg 2021;73(4):1445-55.
DOI: 10.1016/j.jvs.2020.10.026
Stricker H, Jacomella V. Stent-assisted angioplasty at the level of the common femoral artery bifurcation: Midterm outcomes. J Endovasc Ther 2004;11:281-6.
DOI: 10.1583/03-1169.1
Azéma L, Davaine JM, Guyomarch B, et al. Endovascular repair of common femoral artery and concomitant arterial lesions. Eur J Vasc Endovasc Surg 2011;41(6):787-93.
DOI: 10.1016/j.ejvs.2011.02.025
López JF, Magne JL, Champetier J. The femoral artery and flexion of the hip joint. Surg Radiol Anat 1989;11(4):275e81.
DOI: 10.1007/BF02098696
Lim CS, Gohel MS, Shepherd AC, et al. Iliac artery compression in cyclists: mechanisms, diagnosis and treatment. Eur J Vasc Endovasc Surg 2009;38(2):180-6.
DOI: 10.1016/j.ejvs.2009.03.024
Gogineni A, Ravigururajan TS. Flow Dynamics and Wall Shear Stresses in a Bifurcated Femoral Artery. J Biomed Eng Med Devic 2017;2(3).
DOI: 10.4172/2475-7586.1000130
Kornet L, Lambregts J, Hoeks AP, et al. Differences in near-wall shear rate in the carotid artery within subjects are associated with different intima-media thicknesses. Arterioscler Thromb Vasc Biol 1998;18(12):1877-84.
DOI: 10.1161/01.ATV.18.12.1877
Morris GC Jr, Edwards E, Cooley DA , et al. Surgical importance of profunda femoris artery. Analysis of 102 cases with combined aortoiliac and femoropopliteal occlusive disease treated by revascularization of deep femoral artery. Arch Surg 1961;82:32-7.
DOI: 10.1001/archsurg.1961.01300070036005
Mills JL, Taylor SM, Fujitani RM. The role of the deep femoral artery as an inflow site for infrainguinal revascularization. J Vasc Surg 1993;18(3):416-23. DOI : 10.1067/ mva.1993.48445
DOI: 10.1016/0741-5214(93)90259-O
Goldstone J, Malone JM, Moore WS. Importance of the profunda femoris artery in primary and secondary arterial operations for lower extremity ischemia. Am J Surg 1978;136(2):215-20.
DOI: 10.1016/0002-9610(78)90231-3
Nguyen BN, Amdur RL, Abugideiri M, et al. Postoperative complications after common femoral endarterectomy. J Vasc Surg 2015;61(6):1489-94.e1.
DOI: 10.1016/j.jvs.2015.01.024
McGovern PJ Jr, Stark KR, Kaufman JL, et al. Management of common femoral artery occlusion: a report of ten cases. J Cardiovasc Surg 1987;28:38-41.
Archie JP Jr, Feldtman RW. Common femoral artery atherosclerotic occlusion. Difficult to diagnose but easy to treat. Am Surg 1982;48:339-40.
Mukherjee D, Inahara T. Endarterectomy as the procedural of choice for atherosclerotic occlusive lesions of the common femoral artery. Am J Surg 1989;157:498-500.
DOI: 10.1016/0002-9610(89)90644-2
Springhorn ME, Kinney M, Littooy FN, et al. Inflow atherosclerotic disease localized to the common femoral artery: treatment and outcome. Ann Vasc Surg 1991;5:234-40.
DOI: 10.1007/BF02329379
Nelson PR, Powell RJ, Schermerhorn ML, et al. Early results of external iliac artery stenting combined with common femoral artery endarterectomy. J Vasc Surg 2002;35:1107-13.
DOI: 10.1067/mva.2002.124374
Savolainen H, Hanse A, Diehm N, et al. Small is beautiful: why profundaplasty should not be forgotten. World J Surg 2007;31:2058-61.
DOI: 10.1007/s00268-007-9188-y
Kechagias A, Ylonen K. Long-term outcome after isolated endarterectomy of the femoral bifurcation. World J Surg 2008;32:51-4.
DOI: 10.1007/s00268-007-9309-7
Van Himbeeck FJ, van Knippenberg LA, Niessen MC, van Griethuysen AJ. Wound infection after arterial surgical procedures. Eur J Vasc Surg 1992;6:494-8.
DOI: 10.1016/S0950-821X(05)80622-X
Stewart AH, Eyers PS, Earnshaw JJ. Prevention of infection in peripheral arterial reconstruction: a systematic review and meta-analysis. J Vasc Surg 2007;46:148-55.
DOI: 10.1016/j.jvs.2007.02.065
Cordon A, Aillet S, Jarno P, et al. Endarterectomy of the femoral tripod: long-term results and analysis of failure factors. Ann Chir 2001;126:777-82.
Derksen WJM, Verhoeven BAN, van de Mortal RHW, et al. Risk factors for surgical-site infection following common femoral artery endarterectomy. Vasc Endovasc Surg 2009;43:69-75.
DOI: 10.1177/1538574408323502
Ballotta E, Gruppo M, Mazzalai F, et al. Common femoral artery endarterectomy for occlusive disease: an 8-year single- center prospective study. Surgery 2010;147(2):268-74.
DOI: 10.1016/j.surg.2009.08.004
Van Himbeeck FJ, van Knippenberg LA, Niessen MC, et al. Wound infection after arterial surgical procedures. Eur J Vasc Surg 1992;6:494-8.
DOI: 10.1016/S0950-821X(05)80622-X
Stewart AH, Eyers PS, Earnshaw JJ. Prevention of infection in peripheral arterial reconstruction: a systematic review and meta-analysis. J Vasc Surg 2007;46:148-55.
DOI: 10.1016/j.jvs.2007.02.065
Boltz MM, Hollenbeak CS, Julian KG, et al. Hospital costs associated with surgical site infections in general and vascular surgery patients. Surgery 2011;150(5):934-42.
DOI: 10.1016/j.surg.2011.04.006
Dimick JB, Chen SL, Taheri PA, et al. Hospital costs associated with surgical complications: a report from the private- sector National Surgical Quality Improvement Program. J Am Coll Surg 2004;199:531-7.
DOI: 10.1016/j.jamcollsurg.2004.05.276
Khan NA, Quan H, Bugar JM, et al. Association of postoperative complications with hospital costs and length of stay in a tertiary care center. J Gen Intern Med 2006;21:177-80.
DOI: 10.1007/s11606-006-0254-1
Davenport DL, Henderson WG, Khuri SF, et al. Preoperative risk factors and surgical complexity are more predictive of costs than postoperative complications: a case study using the National Surgical Quality Improvement Program (NSQIP) database. Ann Surg 2005;242:463-8;discussion 468-71.
DOI: 10.1097/01.sla.0000183348.15117.ab
Soga Y, Tomoi Y, Sato K, et al. Clinical outcome after endovascular treatment for isolated common femoral and popliteal artery disease. Cardiovasc. Interv Ther 2013;28:250-7.
Wong G, Lahsaei S, Aoun J, et al. Management of common femoral artery occlusive disease: A review of endovascular treatment strategies and outcomes. Catheter Cardiovasc Interv 2019;93(3):514-21.
DOI: 10.1002/ccd.27983
Imran HM, Hyder ON, Soukas PA. Efficacy and safety of adjunctive drug-coated balloon therapy in endovascular treatment of common femoral artery disease. Cardiovasc Revasc Med 2019;20:210-4.
DOI: 10.1016/j.carrev.2018.06.018
Baumann F, Ruch M, Willenberg T, et al. Endovascular treatment of common femoral artery obstructions. J Vasc Surg 2011;53:1000-6.
DOI: 10.1016/j.jvs.2010.10.076
Siracuse JJ, Van Orden K, Kalish JA, et al. Endovascular treatment of the common femoral artery in the Vascular Quality Initiative. J Vasc Surg 2017;65:1039-46. 52. Morris-Stiff G, Moawad M, Appleton N, et al. Long-term clinical outcome following lower limb arterial angioplasty. Ann R Coll Surg Engl 2011;93:250-4.
DOI: 10.1308/147870811X566394
Kuo TT , Chen PL, Huang CY, et al. Outcome of drug-eluting balloon angioplasty versus endarterectomy in common femoral artery occlusive disease. J Vasc Surg 2019;69:141-7.
DOI: 10.1016/j.jvs.2018.05.225
Dormandy JA, Rutherford RB. Management of peripheral arterial disease (PAD). TA SC working group. Trans Atlantic inter society consensus (TA SC). J Vasc Surg 2000;31:S1-S296.
Mehta M, Zhou Y, Paty PS, et al. Percutaneous common femoral artery interventions using angioplasty, atherectomy, and stenting. J Vasc Surg 2016;64(2):369-79.
DOI: 10.1016/j.jvs.2016.03.418
Johnston KW, Rae M, Hogg-Johnston SA, et al. 5-year results of a prospective study of percutaneous transluminal angioplasty. Ann Surg 1987;206(4):403-13.
DOI: 10.1097/00000658-198710000-00002
Fitzgerald PJ, Ports TA , Yock PG. Contribution of localized calcium deposits to dissection after angioplasty. An observational study using intravascular ultrasound. Circulation 1992;86:64-70.
DOI: 10.1161/01.CIR.86.1.64
De Blic R, Deux JF, Kobeiter H, et al. Initial experience with percutaneous angioplasty of the common femoral artery in de novo stenotic lesions. Ann Vasc Surg 2015;29:1493-500.
DOI: 10.1016/j.avsg.2015.05.002
Paris CL, White CJ, Collins TJ, et al. Catheter-based therapy of common femoral artery atherosclerotic disease. Vasc Med 2011;16:109-12.
DOI: 10.1177/1358863X11404280
Baerlocher MO, Kennedy SA, Rajebi MR, et al. Meta-analysis of drug eluting balloon angioplasty and drug-eluting stent placement for infrainguinal peripheral arterial disease. J Vasc Interv Radiol 2015;26:459-73.
DOI: 10.1016/j.jvir.2014.12.013
Thiney PO, Millon A, Boudjelit T, et al. Angioplasty of the common femoral artery and its bifurcation. Ann Vasc Surg 2015;29:960-7.
DOI: 10.1016/j.avsg.2015.02.001
Dattilo PB, Tsai TT , Kevin Rogers R, et al. Acute and mediumterm outcomes of endovascular therapy of obstructive disease of diverse etiology of the common femoral artery. Catheter Cardiovasc Interv 2013;81:1013-22.
DOI: 10.1002/ccd.24475
Baumann F, Ruch M, Willenberg T, et al. Endovascular treatment of common femoral artery obstructions. J Vasc Surg 2011;53(4):1000-6.
DOI: 10.1016/j.jvs.2010.10.076
Laird JR. Endovascular treatment of common femoral artery disease: Viable alternative to surgery or just another short-term fix. J Am Coll Cardiol 2011;58:799-800.
DOI: 10.1016/j.jacc.2011.01.071
Boufi M, Ejargue M, Gaye M, et al. Systematic review and meta-analysis of endovascular versus open repair for common femoral artery atherosclerosis treatment. J Vasc Surg 2021;73(4):1445-55.
DOI: 10.1016/j.jvs.2020.10.026
Linni K, Ugurluoglu A, Hitzl W, et al. Bioabsorbable Stent Implantation vs. Common Femoral Artery Endarterectomy: Early Results of a Randomized Trial. J Endovasc Ther 2014;21:493-502.
DOI: 10.1583/14-4699R.1
Calligaro K, Balraj P, Moudgill N, et al. Results of polytetrafluoroethylene- covered nitinol stents crossing the inguinal ligament. J Vasc Surg 2013;57(2):421-6.
DOI: 10.1016/j.jvs.2012.05.112
Deloose K, et al. A Study Evaluating the Endovascular Treatment of Subjects With Stenotic or Restenotic Lesions of the Common Femoral Artery With the Supera Vascular Mimetic Implant Compared to Surgical Common Femoral Artery Endarterectomy (SUPERSURG-RCT).
Yamawaki M, Hirano JK, Nakano M, et al. Deployment of Self-Expandable Stents for Complex Proximal Superficial Femoral Artery Lesions Involving the Femoral Bifurcation With or without Jailed Deep Femoral Artery. Catheterization and Cardiovascular Interventions 2013;81:1031-41.
DOI: 10.1002/ccd.24502
Hong SJ, Ko YG, Suh Y, et al. Outcomes of stents covering the deep femoral artery origin. EuroIntervention 2014;10:632-9.
DOI: 10.4244/EIJV10I5A109
Mathisen SR, Akesson M, Lindh M, et al. Kissing stents in the common femoral artery bifurcation for critical limb ischemia: technical description and report of three cases. Vascular 2007;15(4):211-4.
DOI: 10.2310/6670.2007.00037
Thiney PO, Millon A, Boudjelit T, et al. Angioplasty of the common femoral artery and its bifurcation. Ann Vasc Surg 2015;29(5):960-7.
DOI: 10.1016/j.avsg.2015.02.001
Stavroulakis K, Schwindt A, Torsello G, et al. Directional atherectomy with antirestenotic therapy vs drug-coated balloon angioplasty alone for common femoral artery atherosclerotic disease. J Endovasc Ther 2017;25:92-9.
DOI: 10.1177/1526602817748319
Cioppa A, Stabile E, Salemme L, et al. Combined use of directional atherectomy and drug-coated balloon for the endovascular treatment of common femoral artery disease: immediate and one-year outcomes. EuroIntervention 2017;12:1789e94.
DOI: 10.4244/EIJ-D-15-00187
Zeller T, Langhoff R, Rocha-Singh KJ, et al. Directional atherectomy followed by a Paclitaxel-coated balloon to Inhibit restenosis and Maintain vessel patency: Twelve-month results of the DEFINITIVE AR study. Circ Cardiovasc Interv 2017;10.
DOI: 10.1161/CIRCINTERVENTIONS.116.004848
Starodubtsev V, Mitrofanov V, Ignatenko P, et al. Editor's Choice - Hybrid vs. Open Surgical Reconstruction for Iliofemoral Occlusive Disease: A Prospective Randomised Trial. Eur J Vasc Endovasc Surg. 2022 Apr;63(4):557-565.
DOI: 10.1016/j.ejvs.2022.02.002
Gouëffic Y, Della Schiava N, Thaveau F, et al. Stenting or Surgery for De Novo Common Femoral Artery Stenosis. JACC Cardiovasc Interv 2017;10(13):1344-54.
DOI: 10.1016/j.jcin.2017.03.046
Linni K, Ugurluoglu A, Hitzl W, et al. Bioabsorbable stent implantation vs. common femoral artery endarterectomy: early results of a randomized trial. J Endovasc Ther 2014;21(4):493-502.
DOI: 10.1583/14-4699R.1
Rastan A, Zeller T, et al Percutaneous Intervention Versus Surgery in the Treatment of Common Femoral Artery Lesions (PESTO -AFC).
Deloose K, et al. A Study Evaluating the Endovascular Treatment of Subjects With Stenotic or Restenotic Lesions of the Common Femoral Artery With the Supera Vascular Mimetic Implant Compared to Surgical Common Femoral Artery Endarterectomy (SUPERSURG-RCT).
Guo J, Guo L, Tong Z, et al. Directional Atherectomy Is Associated with Better Long-Term Efficiency Compared with Angioplasty for Common Femoral Artery Occlusive Disease in Rutherford 2-4 Patients. Ann Vasc Surg 2018;51:65-71.
DOI: 10.1016/j.avsg.2017.12.004
Dosluoglu HH, Lall P, Cherr GS, et al. Role of simple and complex hybrid revascularization procedures for symptomatic lower extremity occlusive disease. J Vasc Surg 2010;51(6):1425-35.e1.
DOI: 10.1016/j.jvs.2010.01.092
Nelson PR, Powell RJ, Schermerhorn ML, et al. Early results of external iliac artery stenting combined with common femoral artery endarterectomy. J Vasc Surg. 2002;35(6):1107-13.
DOI: 10.1067/mva.2002.124374
Ebaugh JL, Gagnon D, Owens CD, et al. Comparison of costs of staged versus simultaneous lower extremity arterial hybrid procedures. Am J Surg 2008;196(5):634-40.
DOI: 10.1016/j.amjsurg.2008.08.003
Antoniou GA, Sfyroeras GS, Karathanos C, et al. Hybrid endovascular and open treatment of severe multilevel lower extremity arterial disease. Eur J Vasc Endovasc Surg 2009;38(5):616-22.
DOI: 10.1016/j.ejvs.2009.06.016
Matsagkas M, Kouvelos G, Arnaoutoglou E, et al. Hybrid procedures for patients with critical limb ischemia and severe common femoral artery atherosclerosis. Ann Vasc Surg 2011;25(8):1063-9.
DOI: 10.1016/j.avsg.2011.07.010
Balaz P, Rokosny S, Wohlfahrt P, et al. Early and late outcomes of hybrid endovascular and open repair procedures in patients with peripheral arterial disease. Vasa 2013;42(4):292-300.
DOI: 10.1024/0301-1526/a000290
Kashyap VS, Pavkov ML, Bena JF, et al. The management of severe aortoiliac occlusive disease: endovascular therapy rivals open reconstruction. J Vasc Surg. 2008;48(6):1451-7.
DOI: 10.1016/j.jvs.2008.07.004